Why I Won’t Give a Sample of my DNA to Decode Genetics
By Alda Sigmundsdóttir,
The Iceland Weather Report
| 05. 19. 2014
Untitled Document
Last week I posted a picture on our Facebook page of the contents of an envelope I received from the company Decode Genetics, in which they kindly request that I give them a sample of my DNA. I made some glib remark about swabbing the dog, but didn’t really explain the full story.
Basically it is like this: Decode wants 100,000 Icelanders to give them DNA samples to put into their database. Apparently because the Icelandic population is so homogenous, our DNA contains clues as to what causes specific diseases. Decode wants to study this [indeed, Decode's entire existence is built around studying this] and make tons of money selling their findings to pharmaceutical and other medical sector companies. BUT for Decode to be able to do so they also have to have access to our medical records.
In return for our contribution, Decode is offering to give us a t-shirt.
Let us just take a moment to contemplate this stellar offer.
/ a moment.
Now, maybe giving up my DNA and a large chunk of my privacy is...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...